RN7SL100P

Across TCGA pan-cancer cohorts, RN7SL100P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL100P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RN7SL100P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL100P expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

DLBC, UCEC, and ACC are the cancer types where RN7SL100P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	II,III,IV	0.279	0.854	<.001	114	view →
UCEC	OS	Tertile	III,IV	0.089	0.616	<.001	108	view →
ACC	OS	Tertile	II,III,IV	0.135	0.658	.010	27	view →
BLCA	DFS	Tertile	All	0.328	0.535	.011	21	view →
OV	DFS	Tertile	IV	0.283	0.503	.016	18	view →
PAAD	DFS	Tertile	II,III,IV	0.174	0.441	.012	18	view →
THCA	DFS	Tertile	III,IV	0.694	0.936	.002	18	view →
SARC	OS	Tertile	All	0.548	0.751	.012	12	view →
PRAD	DFS	Tertile	All	0.797	0.939	.014	12	view →
COAD	OS	Tertile	All	0.595	0.814	.019	9	view →
LUAD	DFS	Tertile	All	0.969	0.799	.029	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL100P–DLBC (DFS)

Open the DLBC breakdown →